Close

UPDATE: Rosetta Genomics (ROSG) Ramps On New Buy Rating; Analyst Sees 238% Upside

Go back to UPDATE: Rosetta Genomics (ROSG) Ramps On New Buy Rating; Analyst Sees 238% Upside
Genomic Health, Inc. (NASDAQ: GHDX) Delayed: 63.44 --0 (-0%)
Previous Close $63.44    52 Week High $35.79 
Open $12.85    52 Week Low $22.00 
Day High $63.44    P/E N/A 
Day Low $63.44    EPS $-0.42 
Volume 32,882       

ROSETTA GENOMICS (NASDAQ: ROSG) Delayed: 0.43 --0 (-0%)
Previous Close $0.43    52 Week High $1.84 
Open $0.02    52 Week Low $0.55 
Day High $0.43    P/E N/A 
Day Low $0.43    EPS $0.00 
Volume 1,347